Our ongoing research aims to verify whether this synthetic lethal drug-loaded magnetic-driven hydrogel micro-robot can inhibit the in vivo growth of osteosarcoma under the guidance of genomic features and the specific mechanism of CDK1 inhibition in sensitizing osteosarcoma chemotherapy. Here, CDK1 is linked to osteosarcoma.